Key result
Early elevated RDW precedes severe cardiorenal disease in a novel gene-edited rat model.
Why the study?
The significance of the association between increased RDW and the onset and progression of cardiovascular and renal diseases was unknown.
This study identifies a novel quantitative trait locus for RDW in a rat model, providing experimental evidence that genetic predisposition for increased RDW precedes poor cardio-renal outcomes.
Answers are grounded in this paper and cite their sources.
RDW genetic variants should not yet influence patient management; animal data leave their causal role in early cardiovascular risk open.
Red blood cell distribution width (RDW) is a measurement of the variation in size and volume of red blood cells (RBCs). Increased RDW, indicating a high heterogeneity of RBCs, is prominently associated with a variety of illnesses, especially cardiovascular diseases. However, the significance of this association to the onset and progression of cardiovascular and renal diseases is unknown. We hypothesized that a genetic predisposition for increased RDW is an early risk factor for cardiovascular and renal comorbidities. Since there is no known animal model of increased RDW, we examined a CRISPR/Cas9 gene-edited rat model (RfflTD) which presented with features of hematologic abnormalities as well as severe cardiac and renal comorbidities. A mass-spectrometry based quantitative proteomic analysis indicated anemia of these rats presented with significant downregulation of hemoglobin and haptoglobin. Decreased hemoglobin and increased RDW were further observed in RfflTD through complete blood count. Next, a systematic temporal assessment detected an early increased RDW in RfflTD, which was prior to the development of other comorbidities. The primary mutation of RfflTD is a 50bp deletion in a non-coding region, whereby, our study has serendipitously identified this locus as a novel quantitative trait locus (QTL) for RDW. To our knowledge, our study is the first to experimentally pinpoint a QTL for RDW and provides a novel genetic rat model mimicking the clinical association of increased RDW with poor cardio-renal outcomes.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2020) studied Cardiovascular and renal comorbidities. CRISPR/Cas9 gene-edited rat model (RfflTD) was evaluated on Onset and progression of cardiovascular and renal diseases. A CRISPR/Cas9 gene-edited rat model (RfflTD) demonstrated that early increased RDW precedes the development of severe cardiac and renal comorbidities, identifying a novel QTL for RDW.
Synapse has enriched 10 related papers. Consider them for comparative context: